The Study of Tamoxifen and Raloxifene (STAR trial) for the prevention of breast cancer.

dc.contributor.authorKelminski, Ann
dc.date.accessioned2016-10-25T23:01:07Z
dc.date.available2016-10-25T23:01:07Z
dc.date.issued2002-09
dc.identifier.issn0017-8594
dc.identifier.pubmed12422387
dc.identifier.urihttp://hdl.handle.net/10524/53680
dc.language.isoeng
dc.subject.meshAntineoplastic Agents, Hormonal/therapeutic use
dc.subject.meshBreast Neoplasms/prevention & control
dc.subject.meshEligibility Determination
dc.subject.meshFemale
dc.subject.meshHawaii/epidemiology
dc.subject.meshHumans
dc.subject.meshPatient Participation
dc.subject.meshRaloxifene Hydrochloride/therapeutic use
dc.subject.meshRandomized Controlled Trials as Topic
dc.subject.meshRisk Factors
dc.subject.meshTamoxifen/therapeutic use
dc.titleThe Study of Tamoxifen and Raloxifene (STAR trial) for the prevention of breast cancer.
dc.typeArticle
dc.type.dcmiText
prism.number9
prism.pagerange209-10
prism.publicationnameHawaii Medical Journal
prism.volume61

Files

Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
2002-09p209-210.pdf
Size:
244.54 KB
Format:
Adobe Portable Document Format